|
Patient id: (b)(6).It was reported the initial procedure was to treat the proximal right anterior tibial (at) artery on (b)(6) 2025.A 3.0x38mm esprit btk scaffold was implanted without issue.On (b)(6) 2026, the patient returned with acute limb ischemia and pain in both legs however the left leg pain was more severe.Bilateral angiography showed left superficial femoral artery (sfa) chronic total occlusion (cto) with 70% popliteal stenosis and occluded tibial vessels.The angiography showed 90% sfa, popliteal, and proximal at stenosis with in-stent restenosis noted within the esprit scaffold.Attempted intervention of the left sfa was unsuccessful as the balloon catheter was unable to cross the lesion.No right leg intervention was performed.No additional information was provided.
|
|
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.The reported patient effects of ischemia, stenosis and pain are listed in the esprit btk everolimus eluting resorbable scaffold systems instructions for use as known patient effects of scaffold procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.C3: 1 per year was entered; however, the frequency is 1 dose per implant.
|